Conditions | Yield |
---|---|
With potassium carbonate |
Conditions | Yield |
---|---|
With potassium carbonate | |
With potassium carbonate In acetone for 20h; Reflux; |
Conditions | Yield |
---|---|
unter Wasserstoff; |
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 2: alkaline aqueous H2O2 3: potassium carbonate View Scheme | |
Multi-step reaction with 3 steps 2: alkaline aqueous H2O2 3: potassium carbonate View Scheme | |
Multi-step reaction with 3 steps 1: hexan-1-amine / 6 h / Heating 2: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C 3: potassium carbonate / acetone / 20 h / Reflux View Scheme |
5-allyl-2-hydroxy-3-methoxybenzaldehyde
myristicin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: alkaline aqueous H2O2 2: potassium carbonate View Scheme | |
Multi-step reaction with 2 steps 1: alkaline aqueous H2O2 2: potassium carbonate View Scheme | |
Multi-step reaction with 2 steps 1: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C 2: potassium carbonate / acetone / 20 h / Reflux View Scheme |
2-allyloxy-3-methoxy-phenol
myristicin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme | |
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme |
2-(allyloxy)-6-methoxyphenol
myristicin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme | |
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme |
myristicin
2-bromo-1-(3-methoxy-4,5-methylenedioxyphenyl)propane
Conditions | Yield |
---|---|
With hydrogen bromide at 20℃; | 99.22% |
myristicin
4-methoxy-6-propyl-benzo[1,3]dioxole
Conditions | Yield |
---|---|
With 1% Pd on activated carbon; hydrogen In water at 20℃; under 760.051 Torr; for 12h; Reagent/catalyst; Green chemistry; chemoselective reaction; | 99% |
With ethanol; palladium Hydrogenation; | |
With hydrogen In methanol at 20℃; under 15001.5 Torr; for 2h; Autoclave; |
myristicin
ethyl 2-chloro-2-(hydroxyimino)acetate
ethyl 5-(3-methoxy-4,5-methylenedioxybenzyl)-4,5-dihydroisoxazole-3-carboxylate
Conditions | Yield |
---|---|
With triethylamine In dichloromethane at 20℃; for 24h; | 69% |
myristicin
N-hydroxy-4-methoxy-benzenecarboximidoyl chloride
5-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-(4-methoxyphen-yl)-4,5-dihydroisoxazole
Conditions | Yield |
---|---|
With triethylamine In dichloromethane at 0 - 20℃; for 17h; | 68% |
With triethylamine In dichloromethane for 24h; | 67% |
Conditions | Yield |
---|---|
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux; | A 20% B 55% |
Conditions | Yield |
---|---|
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux; | A 10% B 54% |
myristicin
3-(3-methoxy-4,5-methylenedioxy-phenyl)-2-propen-1-ol
Conditions | Yield |
---|---|
With selenium(IV) oxide In 1,4-dioxane; water at 85℃; for 0.0833333h; | 24% |
myristicin
MMDA
Conditions | Yield |
---|---|
With ammonium hydroxide; Spirulina platensis phenylalanine ammonia-lyase In acetone at 37℃; for 1h; pH=8; Reagent/catalyst; Enzymatic reaction; | 15.3% |
Conditions | Yield |
---|---|
With trifluorormethanesulfonic acid In dichloromethane for 0.25h; Reflux; | A 10% B 2% |
Conditions | Yield |
---|---|
With benzene |
Conditions | Yield |
---|---|
With diethyl ether im Dunkeln; |
myristicin
trans-isomyristicin
Conditions | Yield |
---|---|
With potassium hydroxide | |
With sodium under 10 Torr; beim Destillieren; |
Conditions | Yield |
---|---|
With potassium permanganate; water | |
Multi-step reaction with 3 steps 1.1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C 2.1: pyridine; ozone / methanol; chloroform / -15 - 0 °C 3.1: ammonium hydroxide; iodine / tetrahydrofuran; water / 16 h / 20 °C 3.2: 4 h / Reflux View Scheme | |
Multi-step reaction with 3 steps 1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C 2: pyridine; ozone / methanol; chloroform / -15 - 0 °C 3: urea hydrogen peroxide adduct; sodium hydroxide / methanol; water / Reflux View Scheme | |
Multi-step reaction with 3 steps 1: tetrabutylammomium bromide; potassium hydroxide / 0.67 h / 100 °C / Neat (no solvent) 2: pyridine; ozone / methanol; chloroform / -15 °C 3: urea hydrogen peroxide adduct; sodium hydroxide / methanol; water / 1.5 h / Reflux View Scheme | |
Multi-step reaction with 3 steps 1: potassium hydroxide / 0.67 h / 100 °C 2: ozone; pyridine / methanol; chloroform / -15 °C 3: urea hydrogen peroxide adduct / methanol / 1.5 h / Reflux View Scheme |
myristicin
A
5-methoxy-3,4-methylenedioxybenzoic acid
B
(7-methoxy-benzo[1,3]dioxol-5-yl)-acetic acid
Conditions | Yield |
---|---|
With potassium permanganate; ethanol; sodium sulfate Reagens 4: Magnesiumcarbonat; |
myristicin
2′,3′-dihydroxymyristicin
Conditions | Yield |
---|---|
With potassium hydroxide; potassium permanganate |
myristicin
Conditions | Yield |
---|---|
With ethanol; iodine; mercury(II) oxide |
myristicin
Conditions | Yield |
---|---|
With palladium on activated charcoal; Lindlar's catalyst; ozone; ethyl acetate at -12℃; Erwaermen des Reaktionsprodukts mit Methanol, Hydroxylamin-hydrochlorid und wss. Kalilauge; |
myristicin
4,6-dibromo-5-(2,3-dibromo-propyl)-7-methoxy-benzo[1,3]dioxole
Conditions | Yield |
---|---|
With bromine; acetic acid at 0℃; |
myristicin
Conditions | Yield |
---|---|
With cis-nitrous acid |
Conditions | Yield |
---|---|
With trichlorophosphate 1) chlorobenzene, 2 h, 0 deg C, 2) chlorobenzene, 80 h, r.t.; Yield given. Multistep reaction; |
myristicin
A
trans-isomyristicin
Conditions | Yield |
---|---|
With potassium hydroxide In ethanol for 15h; Heating; Yield given. Yields of byproduct given; | |
With potassium hydroxide In ethanol for 15h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts; |
Conditions | Yield |
---|---|
at 0℃; |
The Myristicin is an organic compound with the formula C11H12O3. The IUPAC name of this chemical is 4-methoxy-6-prop-2-enyl-1,3-benzodioxole. With the CAS registry number 607-91-0, it is also named as 6-Allyl-4-methoxy-1,3-benzodioxole. The product's categories are Miscellaneous Natural Products; Aromatic Phenols. Besides, it should be stored in a closed cool and dry place.
It speculated myristicin could be metabolized to MMDA, a psychoactive drug related to MDA, in the liver. This speculation has never been confirmed and studies with the closely related compounds asarone and safrole demonstrated the proposed transamination reactions did not take place in humans. There are also data to suggest myristicin can alter the toxicity and/or metabolic pathway of some compounds and it is a weak MAOI.
Physical properties about Myristicin are: (1)ACD/LogP: 3.26; (2)ACD/LogD (pH 5.5): 3.26; (3)ACD/LogD (pH 7.4): 3.26; (4)ACD/BCF (pH 5.5): 178.18; (5)ACD/BCF (pH 7.4): 178.18; (6)ACD/KOC (pH 5.5): 1421.57; (7)ACD/KOC (pH 7.4): 1421.57; (8)#H bond acceptors: 3; (9)#Freely Rotating Bonds: 3; (10)Polar Surface Area: 27.69 Å2; (11)Index of Refraction: 1.539; (12)Molar Refractivity: 53 cm3; (13)Molar Volume: 169 cm3; (14)Polarizability: 21.01×10-24cm3; (15)Surface Tension: 39.8 dyne/cm; (16)Density: 1.137 g/cm3; (17)Flash Point: 89.8 °C Enthalpy of; (18)Vaporization: 49.43 kJ/mol; (19)Boiling Point: 276.5 °C at 760 mmHg; (20)Vapour Pressure: 0.00805 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O1c2cc(cc(OC)c2OC1)C\C=C
(2)InChI: InChI=1/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(3)InChIKey: BNWJOHGLIBDBOB-UHFFFAOYAE
(4)Std. InChI: InChI=1S/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(5)Std. InChIKey: BNWJOHGLIBDBOB-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | oral | 400mg/kg (400mg/kg) | BEHAVIORAL: GENERAL ANESTHETIC LIVER: FATTY LIVER DEGERATION | American Journal of Pharmacy Vol. 80, Pg. 563, 1909. |
guinea pig | LDLo | subcutaneous | 2gm/kg (2000mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS LIVER: OTHER CHANGES | American Journal of Pharmacy Vol. 80, Pg. 563, 1909. |
human | TDLo | oral | 5700ug/kg (5.7mg/kg) | BEHAVIORAL: WAKEFULNESS BEHAVIORAL: EUPHORIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Journal of Neuropsychiatry. Vol. 2, Pg. 205, 1961. |
rabbit | LDLo | subcutaneous | 900mg/kg (900mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS LIVER: OTHER CHANGES | American Journal of Pharmacy Vol. 80, Pg. 563, 1909. |
rat | LD50 | oral | 4260mg/kg (4260mg/kg) | Journal of Agricultural and Food Chemistry. Vol. 30, Pg. 563, 1982. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View